AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis (Q64640522)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis |
clinical trial |
Statements
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis (English)
0 references
16 November 2012
0 references
13 July 2015
0 references
359
0 references
18 year
0 references
65 year
0 references